Dr. James Pingpank Jr. earned his medical degree from the George Washington University School of Medicine. He completed his general surgery residency at the University of Connecticut and his surgical oncology fellowship at Fox Chase Cancer Center. He also completed a research fellowship at the University of Pennsylvania.
Dr. Pingpank currently practices as a surgical oncologist at the University of Pittsburgh, where he also serves as Associate Professor of Surgery. Some of his special areas of interest include cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant peritoneal mesothelioma.
Dr. Pingpank advocates for regional treatment of advanced abdominal malignancies, such as when malignant peritoneal mesothelioma spreads beyond the peritoneal lining of the abdominal cavity.
Advocate of Regional Treatment
Dr. Pingpank advocates for regional treatment of advanced abdominal malignancies, such as when malignant peritoneal mesothelioma spreads beyond the peritoneal lining of the abdominal cavity. Unlike systemic chemotherapy, HIPEC targets tumors directly, which helps to make it more effective and have less side effects. It is paired with cytoreduction, surgical removal of all visible tumors within the abdominal cavity. Then, HIPEC is delivered, bathing the abdominal cavity in chemotherapy for about 90 minutes to help kill any residual cancer cells.
When facing a diagnosis of an asbestos-related abdominal malignancy such as mesothelioma, it is crucial to find the right treatment right away. With Dr. James Pingpank, you are in good hands. Contact Dr. Pingpank today.